Clorox surprised Wall Street with a quarter that beat sales estimates, raking in $1.95 billion—slightly down from last year but still ahead of predictions. Their earnings per share also edged above forecasts. But the good news fades when looking ahead: full-year profit guidance is weaker than expected, and operating margins nosedived from 21% to just under 11%. The company, which began in 1913 with bleach and now spans skincare, salad dressing, and kitty litter, faces growth limits due to reliance on a few major retailers. While revenue has declined over the past three years, analysts see strong upside ahead—potentially driven by new products. So while this quarter was a win, investors should watch closely for signs of recovery in profitability and long-term momentum.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
